IMPORTANCE Over the last 25 years, illicit cannabis use and cannabis use disorders have increased among US adults, and 28 states have passed medical marijuana laws (MML). Little is known about MML and adult illicit cannabis use or cannabis use disorders considered over time.
O ver the last 20 years, laws and attitudes regarding cannabis have changed. As of November 2016, 28 states have passed medical marijuana laws (MML). Many adults now favor legalizing recreational use, 1 and fewer view cannabis as risky. 2 Despite this view, while some can use cannabis without harm, 3, 4 potential consequences include impaired functioning, [3] [4] [5] [6] [7] vehicle crashes, [8] [9] [10] [11] emergency department visits, 12 psychiatric symptoms, [13] [14] [15] [16] and addiction. 3, [17] [18] [19] Over time, the prevalence of adult illicit use and related consequences has increased. 10, 12, 17, [19] [20] [21] [22] [23] [24] [25] [26] Thus, identifying factors underlying increased adult illicit use is important. State MML may be one such factor.
18
Little is known about MML and adult cannabis outcomes. Two national studies 17, 27 showed greater use and DSM-IV-diagnosed disorders in MML states but did not examine differences before and after MML. One national study 28 did so, finding increased post-MML cannabis use and cannabis disorders. However, this study only addressed 2004 to 2012, adults 20 years and older, and 10 states that changed MML status. 28 To our knowledge, no study of differences before and after MML has used adult national data predating all MML, differentiated between earlier and more recent periods, or separately examined particular states. Differences between states that passed MML early vs late are important because the national normative context differed for early-MML states, when few such laws existed, and late-MML states, enacted when more states had MML. Also, earlier data can show if trends in cannabis use and disorder in late-passing states began prior to their MML. Further, California and Colorado warrant separate, secondary examination. In 1996, when California passed the first MML, its cannabis rates were higher than other states, 29 and thus its MML may have had little additional effect. Colorado (MML passed in 2000) experienced unique policy changes in 2009-2010 (eAppendix 1 in the Supplement) followed by increases in medical user applications from 500 per month to greater than 10 000 per month and from no known dispensaries to greater than 900, 30-34 potentially exerting additional impact on cannabis outcomes during the later period. 35 We examined MML, illicit cannabis use, and cannabis use disorders in 3 cross-sectional adult surveys: the 1991-1992 National Longitudinal Alcohol Epidemiologic Survey (NLAES), 36 weights were adjusted for selection probabilities and nonresponse. Field procedures were similar across surveys, except that the NLAES used paper-and-pencil interviews whereas the NESARC and NESARC-III used computer-assisted interviews. Because trained interviewers used similar procedures in all surveys, respondents were similarly exposed to interview questions, permitting examination of trends over time. 20, 42, [45] [46] [47] Quality assurance included training, supervision, and callbacks to verify respondent data. 36, [39] [40] [41] [42] The NLAES and NESARC protocols and consent procedures were approved by the institutional review boards at the US Bureau of the Census and the Office of Management and Budget; written consent was provided. The NESARC-III protocols and consent procedures were approved by institutional review boards at the National Institutes of Health and Westat; consent was verbal but recorded electronically, as approved by both institutional review boards. Overall response rates were 60% to 84%.
36,39-42
Eleven states in which primary sampling units were not randomly selected in NESARC-III were excluded from analyses ( Table 1) , yielding 41 764 participants from the NLAES, 41 184 from the NESARC, and 35 549 from the NESARC-III, totaling 118 497 participants. Sample demographic characteristics are shown in eTable 1 in the Supplement.
Measures
The Alcohol Use Disorder and Associated Disabilities Interview Schedule (AUDADIS), a structured diagnostic interview, was used to assess substance use and DSM-IV substance use disorders. All 3 surveys included the same questions about illicit use in the prior 12 months, including cannabis. Illicit use was defined to participants as use without a prescription or other than prescribed, eg, to get high (eAppendix 2 in the Supplement). In the NLAES, information about cannabis was assessed only if participants used 12 or more times. For consistency with the NLAES, we analyzed cannabis use and disorders among NESARC and NESARC-III participants who used cannabis 12 or more times. Any illicit cannabis use in the past 12 months was analyzed, providing a consistent timeframe for use and disorders. Participants with DSM-IV cannabis abuse or dependence in the past 12 months were coded positive for cannabis use disorder (abuse and dependence combined because their criteria reflect a single disorder 48 ). All AUDADIS versions included the same core questions covering cannabis disorder criteria. A minor difference between the NLAES and NESARC was that in the NLAES, criteria were assessed with 2 questions-1 on occurrence and 1 on recurrence-while in the NESARC and NESARC-III, single questions were used.
20,45 Also, the NLAES but not the NESARC included 4 items assessing the "social impairment" and "use despite health problems" dependence criteria. Comparisons between DSM-IV cannabis diagnoses in the NLAES with and without these 4 questions yielded nearly identical prevalence (1.12% vs 1.06%, respectively) and nearperfect concordance (κ, 0.98), so these differences had little impact on results. The NESARC and NESARC-III AUDADIS versions also had only minor differences. Four items were slightly reworded, 1 item was in the NESARC but not NESARC-III, and 1 item was in the NESARC-III but not NESARC. DSM-IV cannabis disorder diagnoses with and without these NESARC and NESARC-III items had near-identical prevalence and near-perfect concordance. 20 Thus, these minor differences could not account for the substantial prevalence increases observed between surveys. Test-retest reliability and convergent validity of AUDADIS DSM-IV cannabis disorder diagnoses is documented extensively. 
Statistical Analyses
We examined whether the degree of change between surveys differed in participants by state MML status using differencein-difference (DiD) tests. 67 and included survey weights and stratification variables to account for the complex survey design. Results were inspected for meaningful change from models 1, 2, and 3 if DiD tests gained or lost significance. All P values were 2-tailed, and significance was set at P < .05. Figure 1A) , a significantly greater increase in ever-MML than never-MML states (P = .004). The predicted prevalence of cannabis disorder also increased (1.6 and 1.0 percentage points) in ever-MML and never-MML states (Figure 2A) , also a significantly greater change in the ever-MML states (P = .03).
Results

Descriptive Predicted Prevalences of Illicit Cannabis Use and Disorder
Change Figure 1B and Figure 2B ). Note that in 1991-1992, predicted prevalences of use and disorder were higher in California than other early-MML states (use: 7.59% vs 4.49%; P = .001; disorder: 2.08% vs 1.15%; P = .02). Nevertheless, for use, decreases in California and non-early-MML states (−2.0 vs −1.7 percentage points) did not differ significantly, nor did the slight decreases in cannabis disorder.
In contrast, in the other 5 early-MML states, prevalences of use and disorder increased. The change in remaining early-MML states differed from non-MML states for use (by 2.5 percentage points; P = .004) and disorder (1.1 percentage points; P = .02). Compared with change in never-MML states, increases in use were significantly greater in late-MML states (P = .01), California (P = .04), and Colorado (P = .03) ( Table 3 ) ( Figure 1C ). Comparing increases in prevalence of cannabis disorder with never-MML states (the reference group), change in late-MML states was not significant (P = .12) but was greater at a trend level in California (P = .06) and significantly greater in Colorado (P = .04) (Table 3) ( Figure 2C ).
Change During the Later
Parallel Paths Sensitivity Analyses
The pre-MML parallel-path assumption was supported by a lack of difference during the earlier period in changes between 
Discussion
In 3 cross-sectional national surveys spanning 20 years, we investigated whether increases in US adult illicit cannabis use and cannabis use disorders followed implementation of MML. Over the entire period, predicted prevalences of illicit use and disorders increased to a greater degree in states that passed MML than in other states. Holding population size and demographic distributions constant from 1991 to 2012, an additional 1.1 million adult illicit cannabis users and an additional 500 000 adults with a DSM-IV-diagnosed cannabis disorder may be attributable to medical marijuana law passage. Given the potential consequences of use and persistent disability associated with cannabis use disorders, 3 (The lack of significant differences in early-MML states could be due to absence of strong lagged effects, waning MML effects over time, or local factors.) Our inference that MML contributed to increased illicit use in late-MML states is strengthened by the lack of such differences in late-MML states during the earlier period (eTable 4 in the Supplement). Further, greater increases in cannabis use and disorder in Colorado than in never-MML states suggests that well-documented 2009-2010 policy changes and dispensary proliferation (eAppendix 1 in the Supplement) contributed to increases in use and disorder, particularly because similar increases did not occur there during the earlier period (eTable 4 and eFigures 1 and 2 in the Supplement). Substantial increases also occurred in California during 2, 3 to be an important consideration in analyzing the unintended consequences of state medical marijuana laws for outcomes such as illicit cannabis use.
Colorado's legal stance towards caregivers and dispensaries. Colorado passed its medical marijuana law in 2000. This law had a provision for caregivers, which the Colorado Department of Public Health and Environment (CDPHE) limited to five patients per caregiver. In 2007, a Denver District Judge ruled that the five-patient limit for caregivers violated state requirements, and overturned the rule. While in theory, that opened the door for caregivers to claim an unlimited number of patients and begin operating medical marijuana commercial operations (i.e., dispensaries), few did because of fear of federal prosecution. Attempts to reinstate the limit were unsuccessful. Subsequent to these legal changes to the distribution system for medical marijuana, data suggest that attitudes, availability, and use increased 5 , as did cannabis-involved fatal motor vehicle crashes 6 .
Changes in
Other early-MML states and the Ogden Memo. A literature search of Pubmed, Scopus, Google Scholar and Google using the words "marijuana" or "cannabis" and the state name did not indicate other early-passing states (California, Oregon, Maine, Nevada) with accurate, comprehensive documentation of analogous post-Ogden policy changes with accompanying increases in medical marijuana applications and dispensaries. The lack of such changes was recently descriptively reviewed in a publication that should be online shortly 7 . The Public Health Division of the Oregon Health Authority reported that medical marijuana card applications increased steadily since 1999, with a possible increase in the yearly rate in 2008, but without data on accompanying changes in the prevalence of cannabis-related consequences 8 , while Oregon did not permit legal medical marijuana dispensaries until 2015 3 .
While many qualitative sources of information (e.g., news reports and observations by those living in California) have suggested that California experienced equivalent rapid growth and proliferation of medical marijuana dispensaries since the Ogden Memo 9 , California's lack of centralized recordkeeping of permits and dispensaries 10 has limited research there to cross-sectional studies of dispensaries within cities or counties 10, 11 . This has limited knowledge about policy changes and their immediate consequences for marijuana use and distribution in California as a whole, but suggests that changes in California be viewed in light of the qualitative information. Early-MML states other than California include Colorado, Maine, Nevada, Oregon, and Washington (laws passed 1998-2000). Trend lines included for visual comparison; they do not imply that the trend was linearly changing over time
